Andreoli L, Pregnolato F, Burlingame R W, Fanelli V, Allegri F, Radice A, Corace C, Sinico R A, Tincani A, Meroni P L
U.O. Reumatologia e Immunologia Clinica, Spedali Civili e Università degli Studi di Brescia.
Reumatismo. 2008 Jul-Sep;60(3):185-91. doi: 10.4081/reumatismo.2008.185.
It was reported by several groups that patients diagnosed as primary antiphospholipid syndrome (PAPS) had developed a full-blown systemic lupus erythematosus (SLE) even after many years of follow-up. Little is known about clinical and/or serological factors that may help predict such evolution. Antinucleosome antibodies (anti-NCS) were described to appear in early stages of SLE, in particular before anti-dsDNA antibodies. The aim of the study is to evaluate the prevalence of anti-NCS in a large cohort of PAPS patients.
IgG and IgM anti-NCS antibodies were detected using a home made assay with H1-stripped chromatin as antigen. Sera from 106 PAPS patients were tested; 52 of them were also tested during the follow-up, at least 2 years apart form the basal sample.
Medium-high titre anti-NCS were found in nearly half of the patients (49/106, 46%), more frequently in those presenting features of "lupus like disease". Most of patients displayed an unchanged pattern of anti-NCS over time. We describe three cases of PAPS patients that developed SLE after many years of follow-up; high titre and low titre anti-NCS were present in two and one of them respectively several years before evolving into SLE.
A significant proportion of PAPS patients displayed medium-high titre anti-NCS, suggesting that the autoimmune response against chromatin may be a relevant event not only in patients with SLE. Further studies are warranted to explore the predictive value of anti-NCS with respect to the evolution from PAPS to SLE.
多个研究小组报告称,被诊断为原发性抗磷脂综合征(PAPS)的患者即使经过多年随访,仍会发展为典型的系统性红斑狼疮(SLE)。对于可能有助于预测这种病情演变的临床和/或血清学因素,人们了解甚少。抗核小体抗体(anti-NCS)被认为出现在SLE的早期阶段,尤其是在抗双链DNA抗体之前。本研究的目的是评估一大群PAPS患者中抗NCS的流行情况。
使用以H1去除的染色质为抗原的自制检测方法检测IgG和IgM抗NCS抗体。检测了106例PAPS患者的血清;其中52例在随访期间也进行了检测,与基础样本检测时间间隔至少2年。
近一半患者(49/106,46%)检测到中高滴度的抗NCS,在那些有“狼疮样疾病”特征的患者中更为常见。大多数患者抗NCS水平随时间无变化。我们描述了3例PAPS患者,在多年随访后发展为SLE;其中2例和1例在发展为SLE的数年前分别存在高滴度和低滴度抗NCS。
相当一部分PAPS患者表现出中高滴度抗NCS,这表明针对染色质的自身免疫反应可能不仅在SLE患者中是一个相关事件。有必要进一步研究探讨抗NCS对PAPS向SLE演变的预测价值。